Stereotaxis (STXS) Net Cash Flow (2010 - 2026)
Stereotaxis (STXS) posted quarterly Net Cash Flow of $1.2 million for Q1 2026, up 168.4% year-over-year from $445226.1 in Q1 2025, and down 59.01% quarter-over-quarter from $2.9 million in Q4 2025.
Stereotaxis (STXS) Net Cash Flow (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Net Cash Flow for 17 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow rose 168.4% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $4.0 million (up 152.42% YoY), while the FY2025 annual figure was $985000.0, up 112.12% from the prior year.
- Net Cash Flow retreated to $1.2 million in Q1 2026 per STXS's latest filing, from $2.9 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $17.2 million in Q2 2023 and bottomed at -$22.6 million in Q4 2022.
- Historically, Net Cash Flow has averaged -$1.5 million across 5 years, with a median of -$2.3 million in 2024.
- Annual changes were most pronounced in 2022 — Net Cash Flow tumbled 5677.19% — and 2023, when it surged 1092.31%.
- Stereotaxis' Net Cash Flow stood at -$22.6 million in 2022, then surged by 89.31% to -$2.4 million in 2023, then surged by 158.97% to $1.4 million in 2024, then jumped by 104.85% to $2.9 million in 2025, then plunged by 59.01% to $1.2 million in 2026.
- Business Quant data shows STXS's Net Cash Flow at $1.2 million in Q1 2026, $2.9 million in Q4 2025, and $3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 746.50 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -42.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -192.18 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 95.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -84.00 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -160.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 17.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 149.00 Mn |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn | 1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 2.92 Mn |
| Dec 31, 2025 | 2.92 Mn |
| Sep 30, 2025 | 3.54 Mn |
| Sep 30, 2025 | 3.54 Mn |
| Jun 30, 2025 | -3.70 Mn |
| Jun 30, 2025 | -3.70 Mn |
| Mar 31, 2025 | -1.75 Mn |
| Mar 31, 2025 | -1.75 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | -4.15 Mn |
| Sep 30, 2024 | -4.15 Mn |
| Jun 30, 2024 | -3.06 Mn |
| Jun 30, 2024 | -3.06 Mn |
| Mar 31, 2024 | -2.32 Mn |
| Mar 31, 2024 | -2.32 Mn |
| Dec 31, 2023 | -2.41 Mn |
| Dec 31, 2023 | -2.41 Mn |